Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

The standard treatment of primary hypoparathyroidism (hypoPT) with oral calcium supplementation and calcitriol (or an analog), intended to control hypocalcemia and hyperphosphatemia and avoid hypercalciuria, remains challenging for both patients and clinicians. In 2015, human parathyroid hormone (hP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ish‐Shalom, Sofia, Caraco, Yoseph, Khazen, Nariman Saba, Gershinsky, Michal, Szalat, Auryan, Schwartz, Phillip, Arbit, Ehud, Galitzer, Hillel, Tang, Jonathan CY, Burshtein, Gregory, Rothner, Ariel, Raskin, Arthur, Blum, Miriam, Fraser, William D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252608/
https://www.ncbi.nlm.nih.gov/pubmed/33666947
http://dx.doi.org/10.1002/jbmr.4274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252608/
https://www.ncbi.nlm.nih.gov/pubmed/33666947
http://dx.doi.org/10.1002/jbmr.4274

Ejemplares similares